1999
DOI: 10.1097/00005392-199902000-00106
|View full text |Cite
|
Sign up to set email alerts
|

p53 and RB Expression Predict Progression in T1 Bladder Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
32
0
4

Year Published

1999
1999
2012
2012

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 62 publications
(39 citation statements)
references
References 0 publications
3
32
0
4
Order By: Relevance
“…It is well known that hypermethylation involving p16 is a frequent mechanism for loss of p16 expression in several common cancers (Merlo et al, 1995;Reed et al, 1996;Wong et al, 1997) but is substantially less frequent in bladder cancer (Spruck et al, 1994). However, regardless of the mechanism, our data support the hypothesis that loss of p16 protein expression is associated with the overexpression of RB recently reported to have similar biological and clinical signi®cance as loss of RB expression in bladder tumors (Cote et al, 1998;Grossman et al, 1998). Moreover, the relationship between overexpression of RB and loss of p16 function also may extend to other tumor types, particularly to those tumor types for which loss of RB function has been implicated as a key factor in their progression including osteosarcomas, ®brosarcomas and non-small cell lung carcinomas (Benedict et al, 1990).…”
Section: Discussionsupporting
confidence: 87%
See 4 more Smart Citations
“…It is well known that hypermethylation involving p16 is a frequent mechanism for loss of p16 expression in several common cancers (Merlo et al, 1995;Reed et al, 1996;Wong et al, 1997) but is substantially less frequent in bladder cancer (Spruck et al, 1994). However, regardless of the mechanism, our data support the hypothesis that loss of p16 protein expression is associated with the overexpression of RB recently reported to have similar biological and clinical signi®cance as loss of RB expression in bladder tumors (Cote et al, 1998;Grossman et al, 1998). Moreover, the relationship between overexpression of RB and loss of p16 function also may extend to other tumor types, particularly to those tumor types for which loss of RB function has been implicated as a key factor in their progression including osteosarcomas, ®brosarcomas and non-small cell lung carcinomas (Benedict et al, 1990).…”
Section: Discussionsupporting
confidence: 87%
“…Nevertheless, despite including RB overexpressors in the normal RB group, patients with alterations in RB still showed a marked increase in progression and decrease in survival rate compared to those individuals whose tumors were scored as RB negative. Because of the similarity in the ®ndings between this study (CordonCardo et al, 1997) and the other report on super®cial tumors (Grossman et al, 1998) in which both absent and overexpression of RB was scored as abnormal, it is likely that there were few, if any, strong RB (presumably p16 negative) staining cases in the ®rst study (Cordon-Cardo et al, 1997) to be misinterpreted as having normal RB function. This is consistent with our yet unpublished observations indicating that most super®cial tumors, particularly Ta lesions, have a heterogeneous staining pattern for both p16 and RB.…”
Section: Discussionsupporting
confidence: 59%
See 3 more Smart Citations